BioProtect
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, BioProtect sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
BioProtect: 4 sponsored US clinical trials, none currently recruiting.
BioProtect sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.
Upper-quartile sponsor footprint
BioProtect sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Prospective Evaluation of a Commercially Available Hydrogel Spacer
NCT05323747
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
NCT05423431
BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007
NCT03400150
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects
NCT00918229
Therapeutic Areas
How the BioProtect archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Prostate Cancer (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
BioProtect: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
BioProtect sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this BioProtect page
4 registered trials is a research-attention snapshot, not an endorsement of BioProtect or any single study.
- None of BioProtect's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Prostate Cancer is the condition BioProtect studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. BioProtect pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.